Inventor
ERWIN SCHREINER
Inventor
AT
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes20%
C07BGeneral methods of organic chemistry20%
PatentTitleYear
12,590,095Crystalline forms of an orally available, selective kit and PDGFR kinase inhibitor202611,970,450Multi-component crystals of an orally available HIF prolyl hydroxylase inhibitor202411,512,068Process for the preparation of crystalline ridinilazole using acid addition salts2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to SANDOZ AG (3)· patent assignee history
2022–2026Based in AT· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SANDOZ AG | 3 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| AT | 3 | 2022–2026 |